TY - JOUR
T1 - Histamine levels in bronchoalveolar lavage from patients with asthma, sarcoidosis, and idiopathic pulmonary fibrosis
AU - Rankin, John A.
AU - Kaliner, Michael
AU - Reynolds, Herbert Y.
N1 - Funding Information:
From the Departments of Pulmonary Medicine, West Haven Vet-erans Hospital and Yale University School of Medicine, New Haven, Corm.. and the Allergic Diseases Section, National In-stitute of Allergy and Infectious Diseases, Bethesda, Md. Supported in parl by the American Lung Association. Received for publication March 28, 1986. Aceqxed for publication Aug. 6. 1986. Reprint requests: John A. Rankin, M.D., Pulmonary Section LCI 105, Yale University School of Medicine, P.O. Box 3333, 333 Cedar St., New Haven, CT 06510. *Dr. Rankin is a recipient of the Charles E. Culpeper Award. Yale University School of Medicine, a Parker B. Francis Fellow of the Puritan Betmet Foundation, and a Research Associate of the Veterans Administration. **Supported by National Heart, Lung, and Blood Institute Grant
PY - 1987/2
Y1 - 1987/2
N2 - Bronchoalveolar lavage (BAL) has been used extensively as a research tool to elucidate immunologic events occurring in the lower respiratory tract of patients with numerous diseases and, most recently, to study patients with asthma. We assessed mast-basophiloid cell numbers and histamine levels with a sensitive histamine assay, lower limit of sensitivity, 25 pg/ml, in BAL fluid from normal individuals (n = 9) and compared these results to those obtained from patients with sarcoidosis (n = 31), idiopathic pulmonary fibrosis (IPF) (n = 8), and mild asthma (n = 7). Patients with sarcoidosis demonstrated a significant increase in total BAL mast-basophiloid cells, 9.6 ± 4.1 × 104, compared to total cells in normal individuals, 0.0, p = 0.03, whereas only patients with IPF had significant elevations in BAL histamine levels. 1315 ± 737 pg/ml, versus levels in normal individuals, 161 ± 54 pg/ml, p = 0.002. A good correlation existed between histamine levels on an aliquot of lysed BAL cells and BAL histamine levels, R = 0.655 and p = 0.02, but not with either the total number or percent mast-basophiloid cells in BAL assessed on Wright's stained cytocentrifuge preparations. Subjects with asthma had both normal numbers of BAL mast-basophiloid cells and histamine levels. These data suggest that (1) BAL histamine levels are easily quantified, (2) the reason(s) for elevations in BAL histamine levels in IPF need further investigation, (3) BAL histamine levels in subjects with asthma are not elevated in those with mild and stable disease, and (4) lumenal mast-basophiloid cells are one major source of BAL histamine.
AB - Bronchoalveolar lavage (BAL) has been used extensively as a research tool to elucidate immunologic events occurring in the lower respiratory tract of patients with numerous diseases and, most recently, to study patients with asthma. We assessed mast-basophiloid cell numbers and histamine levels with a sensitive histamine assay, lower limit of sensitivity, 25 pg/ml, in BAL fluid from normal individuals (n = 9) and compared these results to those obtained from patients with sarcoidosis (n = 31), idiopathic pulmonary fibrosis (IPF) (n = 8), and mild asthma (n = 7). Patients with sarcoidosis demonstrated a significant increase in total BAL mast-basophiloid cells, 9.6 ± 4.1 × 104, compared to total cells in normal individuals, 0.0, p = 0.03, whereas only patients with IPF had significant elevations in BAL histamine levels. 1315 ± 737 pg/ml, versus levels in normal individuals, 161 ± 54 pg/ml, p = 0.002. A good correlation existed between histamine levels on an aliquot of lysed BAL cells and BAL histamine levels, R = 0.655 and p = 0.02, but not with either the total number or percent mast-basophiloid cells in BAL assessed on Wright's stained cytocentrifuge preparations. Subjects with asthma had both normal numbers of BAL mast-basophiloid cells and histamine levels. These data suggest that (1) BAL histamine levels are easily quantified, (2) the reason(s) for elevations in BAL histamine levels in IPF need further investigation, (3) BAL histamine levels in subjects with asthma are not elevated in those with mild and stable disease, and (4) lumenal mast-basophiloid cells are one major source of BAL histamine.
UR - http://www.scopus.com/inward/record.url?scp=0023096950&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0023096950&partnerID=8YFLogxK
U2 - 10.1016/0091-6749(87)90158-8
DO - 10.1016/0091-6749(87)90158-8
M3 - Article
C2 - 2434547
AN - SCOPUS:0023096950
SN - 0091-6749
VL - 79
SP - 371
EP - 377
JO - Journal of Allergy and Clinical Immunology
JF - Journal of Allergy and Clinical Immunology
IS - 2
ER -